These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 3931446)

  • 21. Double-blind randomized comparison of intravenous tocainide versus lidocaine in the treatment of chronic ventricular arrhythmias.
    Mohiuddin SM; Hilleman DE; Mooss AN; Esterbrooks D; Sketch MH; Stengel LA; Butler ML
    Am Heart J; 1987 Aug; 114(2):296-302. PubMed ID: 3111238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias.
    Ryan W; Engler R; LeWinter M; Karliner JS
    Am J Cardiol; 1979 Feb; 43(2):285-91. PubMed ID: 760482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
    Nestico PF; Morganroth J
    Cardiol Clin; 1986 May; 4(2):285-303. PubMed ID: 3085932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mexiletine and tocainide: orally active congeners of lidocaine.
    Wulf BG
    Clin Pharm; 1983; 2(4):340-6. PubMed ID: 6411416
    [No Abstract]   [Full Text] [Related]  

  • 25. Prophylaxis against ventricular arrhythmias in suspected acute myocardial infarction: a comparison of tocainide and disopyramide.
    Allen-Narker RA; Roberts CJ; Marshall AJ; Jordan SC; Barritt DW; Goodfellow RM
    Br J Clin Pharmacol; 1984 Nov; 18(5):725-32. PubMed ID: 6439233
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of ventricular rhythm disturbances.
    Somberg JC; Miura D; Keefe DL
    Am Heart J; 1986 Jun; 111(6):1162-76. PubMed ID: 2424297
    [No Abstract]   [Full Text] [Related]  

  • 27. Tocainide: a new drug for ventricular arrhythmias.
    Volosin KJ; Greenspon AJ
    Am Fam Physician; 1986 Jan; 33(1):233-5. PubMed ID: 3079938
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of tocainide enantiomers on experimental arrhythmias produced by programmed electrical stimulation.
    Uprichard AC; Allen JD; Harron DW
    J Cardiovasc Pharmacol; 1988 Feb; 11(2):235-41. PubMed ID: 2452320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
    Goedel-Meinen L; Hofmann M; Schmidt G; Barthel P; Baedeker W; Blömer H
    Herz; 1988 Jun; 13(3):188-96. PubMed ID: 3136064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic effects of antiarrhythmic drugs.
    Block PJ; Winkle RA
    Am J Cardiol; 1983 Sep; 52(6):14C-23C. PubMed ID: 6414278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tocainide plus quinidine for treatment of ventricular arrhythmias.
    Barbey JT; Thompson KA; Echt DS; Woosley RL; Roden DM
    Am J Cardiol; 1988 Mar; 61(8):570-3. PubMed ID: 3125737
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tocainide in the cardiac ICU.
    Benning CA; Burke PA
    Crit Care Nurse; 1989 Feb; 9(2):45-53. PubMed ID: 2510974
    [No Abstract]   [Full Text] [Related]  

  • 33. New insights into the drug treatment of ventricular arrhythmias.
    Nestico PF; Morganroth J
    Int J Dermatol; 1984 Oct; 23(8):558-64. PubMed ID: 6437997
    [No Abstract]   [Full Text] [Related]  

  • 34. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
    Kreeger RW; Hammill SC
    Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic drug therapy. Recent advances and current status.
    Somberg J
    Cardiology; 1985; 72(5-6):329-48. PubMed ID: 2866841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral tocainide versus disopyramide: a double-blind, randomized, crossover study of outpatients with stable ventricular premature beats.
    McLaran CJ; Hossack KF; Neilson GH; Siskind V
    J Cardiovasc Pharmacol; 1984; 6(4):657-62. PubMed ID: 6206321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiarrhythmic drug therapy for sustained ventricular tachycardia.
    Kienzle MG; Williams PD; Zygmont D; Doherty JU; Josephson ME
    Heart Lung; 1984 Nov; 13(6):614-22. PubMed ID: 6149202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term tocainide therapy for ventricular arrhythmias.
    Winkle RA; Meffin PJ; Harrison DC
    Circulation; 1978 May; 57(5):1008-16. PubMed ID: 639200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic drugs.
    Roy D
    Can Anaesth Soc J; 1986 May; 33(3 Pt 2):S65-7. PubMed ID: 2872953
    [No Abstract]   [Full Text] [Related]  

  • 40. Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing.
    Murray KT; Barbey JT; Kopelman HA; Siddoway LA; Echt DS; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1989 May; 45(5):553-61. PubMed ID: 2498025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.